Matern Child Health J by de Ravello, Lori et al.
Ectopic Pregnancy Among American Indian and Alaska Native 
Women, 2002–2009
Lori de Ravello,
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health 
Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE MS F-74, 
Atlanta, GA 30341, USA
Arianne Folkema,
Division of High-Consequence Pathogens and Pathology, National Center for Emerging and 
Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE 
MS A-30, Atlanta, GA 30333, USA
Scott Tulloch,
Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd 
NE MS E-45, Atlanta, GA 30333, USA
Melanie Taylor,
Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, c/o ADHS, 1845 
E. Roosevelt St., Phoenix, AZ 85006, USA
Brigg Reilley,
HIV/AIDS Prevention Program, Division of Epidemiology and Disease Prevention, Indian Health 
Service, 5300 Homestead Rd NE, Albuquerque, NM 87110, USA
Karen Hoover,
Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd 
NE MS E-45, Atlanta, GA 30333, USA
Robert Holman, and
Division of High-Consequence Pathogens and Pathology, National Center for Emerging and 
Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE 
MS A-30, Atlanta, GA 30333, USA
Andreea Creanga
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health 
Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE MS F-74, 
Atlanta, GA 30341, USA
© Springer Science+Business Media New York (outside the USA) 2014
Correspondence to: Lori de Ravello, leb8@cdc.gov.
HHS Public Access
Author manuscript
Matern Child Health J. Author manuscript; available in PMC 2015 April 01.
Published in final edited form as:













Lori de Ravello: leb8@cdc.gov; Arianne Folkema: AFolkema@regionofwaterloo.ca; Scott Tulloch: sdt2@cdc.gov; Melanie 
Taylor: mdt7@cdc.gov; Brigg Reilley: Brigg.reilley@ihs.gov; Karen Hoover: ffw6@cdc.gov; Robert Holman: 
rch1@cdc.gov; Andreea Creanga: igb4@cdc.gov
Abstract
To examine rates of ectopic pregnancy (EP) among American Indian and Alaska Native (AI/AN) 
women aged 15–44 years seeking care at Indian Health Service (IHS), Tribal, and urban Indian 
health facilities during 2002–2009. We used 2002–2009 inpatient and outpatient data from the 
IHS National Patient Information Reporting System to identify EP-associated visits and obtain the 
number of pregnancies among AI/AN women. Repeat visits for the same EP were determined by 
calculating the interval between visits; if more than 90 days between visits, the visit was 
considered related to a new EP. We identified 229,986 pregnancies among AI/AN women 15–44 
years receiving care at IHS-affiliated facilities during 2002–2009. Of these, 2,406 (1.05 %) were 
coded as EPs, corresponding to an average annual rate of 10.5 per 1,000 pregnancies. The EP rate 
among AI/AN women was lowest in the 15–19 years age group (5.5 EPs per 1,000 pregnancies) 
and highest among 35–39 year olds (18.7 EPs per 1,000 pregnancies). EP rates varied by 
geographic region, ranging between 6.9 and 24.4 per 1,000 pregnancies in the Northern Plains 
East and the East region, respectively. The percentage of ectopic pregnancies found among AI/AN 
women is within the national 1–2 % range. We found relatively stable annual rates of EP among 
AI/AN women receiving care at IHS-affiliated facilities during 2002–2009, but considerable 
variation by age group and geographic region. Coupling timely diagnosis and management with 
public health interventions focused on tobacco use and sexually transmitted diseases may provide 
opportunities for reducing EP and EP-associated complications among AI/AN women.
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Background
Ectopic pregnancy (EP) is a potentially life-threatening condition that develops after the 
implantation of a fertilized ovum outside the endometrial cavity and requires immediate 
evaluation and treatment [1]. Although studies have found that only 1–2 % of pregnancies in 
the United States are ectopic and deaths due to EP are decreasing, EP remains an important 
cause of morbidity and mortality and there are opportunities for prevention [2]. Risk factors 
for EP include: a history of assisted reproductive technology use; endometriosis; previous 
obstetrical or gynecological surgery, including tubal sterilization and cesarean section; tubal 
inflammation and scarring due to infections such as chlamydia and gonorrhea; and 
disruption of ciliary function attributable to smoking [1, 3–6]. Women affected are not only 
exposed to complications from the ectopic pregnancy itself and the related treatment 
procedures, but are also at greater risk of another ectopic pregnancy and infertility [2].
Medical and surgical treatment of ectopic pregnancy is currently provided in both inpatient 
and outpatient settings in the United States. For this reason, obtaining reliable estimates for 
the incidence of ectopic pregnancy at the national level and separately for each racial-ethnic 
group is difficult. The latest such national estimate of 19.7 per 1,000 pregnancies was 
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reported in 1990–1992 using both inpatient National Hospital Discharge Survey and 
outpatient National Hospital Ambulatory Medical Care Survey data [5]. More recent 
attempts to estimate ectopic pregnancy incidence used data from administrative databases 
[1, 5]. These studies suggest that incidence of ectopic pregnancy has not changed 
considerably in the United States in the last decade [2].
In 2012, there were about 46,000 live births to American Indian and Alaska Native (AI/AN) 
women representing 1.2 % of all births in the United States [7]. Yet, little is known about 
maternal health and pregnancy outcomes among this group of women. Research has shown 
that AI/AN women have 1.7 times higher rates of severe maternal morbidity than non-
Hispanic whites [8], but, to our knowledge, there is no recent population-based estimate of 
EP incidence among AI/AN women. Nonetheless, compared to non-Hispanic white women, 
AI/AN women are at higher risk for some of the risk factors for EP, including sexually 
transmitted diseases (STDs; 9) and smoking before, during, and after pregnancy [10–12]. In 
addition, AI/AN women have poorer health outcomes in general, and less access to and 
utilization of health care services [10]. Due to data limitations (e.g. small samples), previous 
studies have not separately examined EP rates and related risk factors among AI/AN women 
[1, 13]. Moreover, given that contemporary EP management is frequently provided on an 
outpatient basis [14], lack of data sources capturing both inpatient and outpatient EP 
admissions has impeded efforts to ascertain current EP rates in the United States and among 
AI/AN women separately [5, 13].
The Indian Health Service (IHS), a federal agency within the US Department of Health and 
Human Services, is responsible for providing health care services to enrolled members of 
federally-recognized tribes [16]. Every year, IHS and its affiliated Tribal and urban Indian 
health programs provide health care services to approximately 2.1 million AI/AN through 
168 hospitals, health centers, and clinics located in 35 states [17]. IHS data include both 
inpatient and outpatient visits, thus serving as a representative data source for analysis of a 
wide range of health outcomes among AI/AN who access care in the IHS/tribal health care 
system. Both the population and the data source are unique. Not only are pregnancy 
outcomes among AI/AN women infrequently studied separately from those of other racial-
ethnic groups in the United States, but AI/AN women also appear to be at higher risk of EP 
and associated complications than other groups of women [18]. Availability of both 
inpatient and outpatient data in the IHS system provides a unique opportunity to study trends 
in EP incidence in this sub-population. Notably, there is no comparable data source for all 
women 15–44 years in the United States. The present analysis examines the rates of and 
trends in EP among pregnancies of AI/AN women aged 15–44 years seen on an inpatient or 
outpatient basis within the IHS/tribal health care system during 2002–2009.
Methods
We used direct and contract health service inpatient and outpatient visit data obtained from 
the IHS National Patient Information Reporting System for the calendar years 2002 through 
2009 [19]. These data consist of all hospital discharge and outpatient visit records from IHS, 
tribally-operated, and IHS-contracted health care facilities that provide healthcare services to 
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eligible AI/AN [20–22]. For the purpose of this analysis, we used both inpatient and 
outpatient visits to capture all EP-related visits in the IHS system.
Inpatient and outpatient EP-associated visits were identified using International 
Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes 633.× or 
761.4 noted on either the inpatient or outpatient visit record [23]. The EP-associated 
hospitalization and outpatient visits were linked using an IHS-encrypted unique patient 
identifier to account for women seen as both inpatient and outpatient for the same EPs. 
Repeat visits for the same EP were determined by calculating the interval between visits; if 
there were more that 90 days between visits, the visit was considered related to a new EP. 
The number of pregnancies was determined by selecting hospitalization and outpatient visit 
records reported with pregnancy listed as one of the diagnoses or procedures (ICD-9-CM 
diagnosis codes V22, V23, V27, V28, 630–677 or procedure codes 72.0–75.9, 69.01, 69.51, 
74.91 or 75.0). Since a woman could have more than one pregnancy during the study period, 
distinct pregnancies were determined by calculating the interval between visits. If there were 
nine months or more between visits, the latter visit was counted as related to a new 
pregnancy. EP-associated rates were expressed as the number of distinct EPs per 1,000 
pregnancies among AI/AN women aged 15–44 years. Average annual EP rates between 
2000 and 2009 were calculated overall, by 5-year age group, and by geographic region.
IHS has 12 administrative areas: Aberdeen (Iowa, Nebraska, North Dakota, and South 
Dakota), Alaska (Alaska), Albuquerque (Colorado, New Mexico, and west Texas), Bemidji 
(Michigan, Minnesota, and Wisconsin), Billings (Montana and Wyoming), California 
(California), Nashville (all states not belonging to another IHS Area), Navajo (the Navajo 
Nation), Oklahoma City (Kansas, Oklahoma, most of Texas), Phoenix (all of Arizona except 
the Tucson and Navajo Areas, Nevada and Utah), Portland (Idaho, Oregon, Washington), 
Tucson (southern Arizona) [21]. For this analysis, we grouped IHS administrative areas into 
the following geographic study regions: Alaska (the IHS Alaska Area), East (the IHS 
Nashville Area), Northern Plains East (the IHS Bemidji Area), Northern Plains West (the 
IHS Aberdeen and Billings Areas), Southern Plains (the IHS Oklahoma City Area), 
Southwest (the IHS Albuquerque, Navajo, Phoenix, and Tucson Areas), and West (the IHS 
California and Portland Areas).
Because age- and region-specific annual rates based on small numbers (fewer than 20 EPs) 
are considered unreliable, and some cells in our study had fewer than 20 EPs, we calculated 
3-year moving averages to smooth the data and gain stability over time with a minimal loss 
of information [24]. We conducted the trend analysis over the study period using Poisson 
regression, controlling for over-dispersion [25]. Comparisons of EP-associated rates 
between groups were made using Poisson regression analysis to determine rate ratios (RRs) 
and 95 % confidence intervals (CIs). Statistical tests were considered significant at p <0.05 
level. Since patients are not individually identifiable per HHS Office for Human Research 
Protections guidance, this analysis was deemed exempt from review by Centers for Disease 
Control and Prevention’s Institutional Review Board.
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We identified a total of 229,986 pregnancies to AI/AN women aged 15–44 years during 
2002–2009. Of these, 2,406 (1.05 %) were coded as EPs, corresponding to an average 
annual rate of 10.5 EPs per 1,000 pregnancies. Recurring EP occurred in 6.1 % (N = 138) of 
women. Of these, nine women had three EPs and two women had four EPs during 2002–
2009. Of the AI/AN women who experienced an EP, 71.0 % were seen only as outpatients, 
9.8 % were seen only as inpatients, and 19.3 % were seen as both outpatients and inpatients 
for the same EP.
The average annual EP rate among AI/AN women was lowest among women aged 15–19 
years (5.5 per 1,000 pregnancies) and highest among those aged 35–39 years (18.7 EPs per 
1,000 pregnancies; Table 1). Compared to AI/AN women aged 15–19 years, women aged 
35–39 years were 3.4 times more likely to have an EP (95 % CI 2.90–4.03; p <.001). The 
average annual EP rates were stable for most age groups throughout the study period, 
without significant year-to-year variations (Fig. 1).
The average annual EP rates varied considerably by geographic region. The lowest EP rates 
were seen in the Northern Plains East region (2000–2009 average of 6.9 EPs per 1,000 
pregnancies) and the highest rates were seen in the East region (2000–2009 average of 24.4 
EPs per 1,000 pregnancies). Compared with EP rates in the Northern Plains East region, 
rates in the East region were 3.6 times greater (95 % CI 2.75–4.57; p <.001) (Table 1). EP 
rates were stable for most regions throughout the study period. Trends in only two regions 
were statistically significantly different over time: EP rates in the West region increased, 
while those in the Southern Plains region decreased (Fig. 2).
Discussion
We analyzed IHS inpatient and outpatient visit data for AI/AN women aged 15–44 years 
and described EP rates and trends during 2002–2009. We found stable rates of EP overall 
with considerable variation by age and region. The 2002–2009 average annual EP rate in our 
study (10.5 EPs per 1,000 pregnancies) was higher than the EP incidence rate reported by 
Hoover et al. [1] for the entire US population (6.4 EPs per 1,000 pregnancies), but far less 
than the rate reported by Trabert et al. [13] for women belonging to the Group Health 
Cooperative, a large health management organization (24.5 EPs per 1,000 pregnancies). The 
latter study included 2,114 women between the ages of 15–44 years living in Washington 
State and western Idaho who sought services through the integrated group practice portion 
of the health care cooperative; the extent to which risk behaviors and access to health care 
differ between their study population and ours is unknown.
Several previous studies have demonstrated considerable variation in EP rates by geographic 
region. One such study looked at 2002–2003 EP rates in the Medicaid population in 
California, Illinois, and New York by race/ethnicity. As in our study, EP rates varied by 
geographic location [26]. In California’s Medicaid population, the overall EP rate was 20.7 
per 1,000 pregnancies and the AI/AN rate was 12.1 per 1,000 pregnancies. In Illinois’ 
Medicaid population, the overall EP rate was 24.3 per 1,000 pregnancies and the AI/AN rate 
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was 31.1 per 1,000 pregnancies. In New York’s Medicaid population, the EP rate was 23.8 
per 1,000 pregnancies and the AI/AN rate was 12.1 per 1,000 pregnancies [26]. AI/AN EP 
rates reported for California’s and New York’s Medicaid populations are in line with our 
study’s average rate of 12.2 per 1,000 pregnancies. Notably, rates among AI/AN women in 
all three states were only lower than the corresponding rates in non-Hispanic black women, 
which ranged between 25.5 and 35.1 EPs per 1,000 pregnancies in New York and Illinois, 
respectively; EP rates among non-Hispanic white women ranged between 22.6 and 24.5 per 
1,000 pregnancies in New York and Illinois, respectively. Not surprisingly, regional 
differences among AI/AN women have been found in relation to other health outcomes. For 
example, invasive cervical cancer incidence rates vary nearly twofold across IHS regions, 
with the highest rates reported in the Southern and Northern Plains regions and the lowest 
rate in the Eastern region and the Pacific Coast region [27]. Our study finds the highest rate 
of EP in the Eastern region and the lowest rate in the Northern Plains region; moreover, the 
corresponding EP rate ratio is considerably greater than the invasive cervical cancer rate 
ratio between the regions with highest and lowest rates of invasive cervical cancer. Taken 
together, these findings indicate an important need for all AI/AN women’s health services to 
include both reproductive health screenings and education on pregnancy complications, 
including ectopic pregnancy.
Several behavioral risks have been linked to EP, including smoking and STDs [1, 3–6]. 
Disruption of ciliary function related to smoking is a reported risk factor for EP [6]. National 
behavioral surveillance data have shown AI/AN women to be at higher risk than white non-
Hispanic women for smoking before, during, and after pregnancy [10–12]. While many IHS, 
Tribal, and urban health care providers may regularly screen patients for tobacco use and 
offer smoking cessation interventions, IHS’s current reported rate of this practice (35.2 %) is 
well below the Healthy People 2020 goal of 80 % [28–30]. There is need to identify key 
opportunities to expand tobacco screening and cessation interventions among AI/AN women 
of childbearing age, including at federally-funded Women, Infants, and Children clinics.
Throughout the United States, there is considerable geographic variation in STD rates 
between racial/ethnic groups [9]; AI/AN women have the second highest rates of chlamydia 
and gonorrhea in the country by race/ethnicity. This disparity is even more pronounced 
among women in older age groups (30–34, 35–39, 40–44 years), where chlamydia and 
gonorrhea rates among AI/AN women are 4.6 to 5.9 times higher than among white non-
Hispanic women [9]. Several regions in our analysis, especially Alaska and Northern Plains 
West regions, have both high EP rates and high STD rates among AI/AN women [9]. It is 
possible that some variations in EP rates may be related to increases in STD screening and 
treatment. However, such an association is difficult to confirm. Still, early STD detection 
may reduce tubal damage by accurate and prompt detection and treatment of lower genital 
tract infections [31, 32]. While screening for STDs is common practice in IHS facilities, and 
especially so among women of reproductive age, coverage and adherence to nationally 
recommended screening guidelines can be further improved [31–34].
Our study has some limitations. The EP rates may be underestimated, as case ascertainment 
was based on IHS administrative data and ICD-9-CM codes. While the majority of these 
data (96 %) were submitted via the IHS’s Resource and Patient Management System, some 
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tribal and urban sites submit data using other data management systems. Diagnoses may be 
incomplete or inaccurate due to use of ICD-9-CM coding to identify EP visits. We also may 
have underestimated the number of EPs and pregnancies, as some AI/AN women who 
normally receive services in the IHS/tribal health system may have accessed obstetric and 
emergency services from outside sources. Therefore, our findings are not generalizable to 
the AI/AN population who do not access care through the IHS system. The total number of 
pregnancies used in our rate calculations may be underestimated, since information on 
miscarriages and abortions is often incomplete. By defining a single pregnancy as a 9-month 
period, we may have introduced bias and underestimated pregnancies by systematically 
excluding short pregnancy intervals. In the data available to us, we could not differentiate 
the type of treatment obtained by women accessing EP care through IHS; it would have been 
especially important to differentiate between types of treatment obtained in the outpatient 
settings. Lastly, the reasons behind the geographical variation in EP rates remain unknown.
To our knowledge, this study is the first to provide EP-associated rates among AI/AN 
women of reproductive age. Overall, only a few, and by and large, older published studies 
have described EP rates by racial/ethnic groups, and even fewer included EP data for AI/AN 
women [26, 35–39]. As with other studies examining EPs [13–15, 40], the majority of 
women with an EP in our study received care in an outpatient setting only. We recommend 
analyzing visits from both inpatient and outpatient settings when conducting EP surveillance 
and/or research to identify the greatest number of EPs.
This study highlights the need for further investigation of the relationship between elevated 
rates of smoking and STDs among AI/AN women and EP rates. Efforts to reduce EP rates 
among AI/AN women should include heightened public awareness of the need for regular 
and routine well-woman exams in order to diagnose and treat EP promptly and to address 
known risk factors for EP, including tobacco use. Improved adherence to national STD 
screening guidelines, prompt treatment of STDs, and tobacco screening and cessation 
interventions may potentially lead to a decline in EP incidence [1, 4, 6].
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Ectopic pregnancy rates among American Indian and Alaska Native women by age group 
and time period: United States, 2002–2009. A Poisson Regression Trend Test of 3-year 
moving averages controlling for over-dispersion was conducted; no significant trends 
detected
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Ectopic pregnancy rates among American Indian and Alaska Native women by region and 
time period: United States, 2002–2009. Regions are Alaska (AK; the IHS Alaska Area), East 
(the IHS Nashville Area), Northern Plains East (NPE; the IHS Bemidji Area), Northern 
Plains West (NPW; the IHS Aberdeen and Billings Areas), Southern Plains (SP; the IHS 
Oklahoma City Area), Southwest (SW; the IHS Albuquerque, Navajo, Phoenix, and Tucson 
Areas), and West (the IHS California and Portland Areas). A Poisson Regression Trend Test 
of 3-year moving averages controlling for over-dispersion was conducted; no significant 
trends detected. Only trends in the Southern Plains and West regions were statistically 
significant (indicated with asterisk)
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Table 1
Ectopic pregnancy rates among American Indian and Alaska native women age 15–44 years, by age group and 
region, 2002–2009, United States
Average annual rate per 1,000 populationa Rate ratio (95 % confidence interval) p value
Age (years)
 15–19 5.5 –b –
 20–24 8.5 1.56 (1.36–1.79) <0.0001
 25–29 13.0 2.38 (2.07–2.73) <0.0001
 30–34 15.0 2.75 (2.37–3.19) <0.0001
 35–39 18.7 3.42 (2.90–4.03) <0.0001
 40–44 14.3 2.62 (2.02–3.36) <0.0001
Region
 Northern Plains East 6.9 –b –
 Alaska 14.9 2.17 (1.73–2.72) <0.0001
 East 24.4 3.55 (2.75–4.57) <0.0001
 Northern Plains West 9.4 1.36 (1.08–1.71) 0.0084
 Southern Plains 10.7 1.56 (1.25–1.95) <0.0001
 Southwest 9.2 1.33 (1.07–1.65) 0.0088
 West 9.5 1.39 (1.09–1.77) 0.0082
Regions are Alaska (the IHS Alaska Area), East (the IHS Nashville Area), Northern Plains East (the IHS Bemidji Area), Northern Plains West (the 
IHS Aberdeen and Billings Areas), Southern Plains (the IHS Oklahoma City Area), Southwest (the IHS Albuquerque, Navajo, Phoenix, and 
Tucson Areas), and West (the IHS California and Portland Areas)
a
The denominator was the number of pregnancies among AI/AN women 15–44 years old seen in IHS facilities during 2002–2009
b
Referent category
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